Clinical relevance and therapeutic potential of IL-38 in immune and non-immune-related disorders
Sign Up to like & getrecommendations! Published in 2022 at "European Cytokine Network"
DOI: 10.1684/ecn.2022.0480
Abstract: Interleukin-38 (IL-38) is the most recent member of the IL-1 family that acts as a natural inflammatory inhibitor by binding to cognate receptors, particularly the IL-36 receptor. In vitro, animal and human studies on autoimmune,… read more here.
Keywords: therapeutic potential; clinical relevance; immune non; relevance therapeutic ... See more keywords